Green chemistry isn’t always a priority for industrial drug discovery chemists.
A 4-point plan can help change this.
By Paul Richardson, special to C&EN.
A version of this story appeared in Volume 103, Issue 15.
Essays from our readers on issues that impact the scientific community.
Though my academic background featured green chemistry staples like biocatalysis, click chemistry, and asymmetric catalysis, I didn’t start my industrial green chemistry journey until I was 8 years into my career.
I was fortunate that the program at Pfizer encompassed discovery chemistry.
I didn’t start my industrial green chemistry journey until I was 8 years into my career.
Author summary: Incentivizing green chemistry in research with a 4-point plan.